Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/19/2010

NSIVE INCOME FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2010 and 2009 (UNAUDITED) Three months ended June 30, Six months ended June 30, 2010 2009 2010 2009 REVENUE - RELATED PARTIES $8,167,849 $20,551,036 $19,571,212 $38,788,581 COST OF SALES - RELATED PARTIES 3,037,847 6,117,409 6,478,728 11,852,468 GROSS PROFIT 5,130,002 14,433,627 13,092,484 26,936,113 SELLING, GENERAL AND ADMINI- STRATIVE EXPENSES 4,069,097 4,014,591 7,566,644 7,145,527 INCOME FROM OPERATIONS 1,060,905 10,419,036 5,525,840 19,790,586 (Interest expense) -- (53,201) -- (105,817) Interest income 3,846 100,779 5,718 186,547 Other expense (418,260) (28,144) (671,970) (73,432) OTHER (EXPENSE) INCOME, NET (414,414) 19,434 (666,252) 7,298 INCOME BEFORE INCOME TAXES 646,491 10,438,470 4,859,588 19,797,884 INCOME TAXES 138,621 123,101 748,123 482,716 NET INCOME $507,870 10,315,369 4,111,465 19,315,168 LESS: Net income attributable to the noncontrolling interest (122,083) (139,071) (464,140) (546,045) NET INCOME ATTRIBUTABLE TO THE COMPANY 385,787 10,176,298 3,647,325 18,769,123 OTHER COMPREHENSIVE INCOME: Foreign currency translation adjustment 766,901 151,289 1,125,269 770,887 COMPREHENSIVE INCOME 1,152,688 10,327,587 4,772,594 19,540,010 COMPREHENSIVE INCOME ATTRI- BUTABLE TO THE NONCONTROLLING INTEREST 163,465 140,300 506,863 559,895 COMPREHENSIVE INCOME ATTRIBUTABLE TO THE COMPANY $989,223 $10,187,287 $4,265,731 $18,980,115 EARNINGS PER SHARE, BASIC AND DILUTED $0.01 $0.14 $0.05 $0.26 WEIGHTED AVERAGE NUMBER OF SHARES, BASIC AND DILUTED 71,333,586 71,333,586 71,333,586 71,333,586 TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2010 (UNAUDITED) AND DECEMBER 31, 2009 June 30, December 31, 2010 2009 (Unaudited) ASSETS CURRENT ASSETS: Cash $5,660,772 $1,848,328 Accounts receivable, trade - related parties, net of allowance for doubtful accounts of $1,307,687 and $1,419,178 as of June 30, 2010 and December 31, 2009, respectively 8,809,737 15,379,312 Inventories
'/>"/>
SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
2. Tiens Biotech Group (USA) Reports First Quarter Results
3. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
4. Tiens Biotech Group (USA) Reports First Quarter Results
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. Yongye Biotechnology International Retains CCG Investor Relations
7. ThirdBiotech Announces Kemeta as Newest Sponsor
8. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
9. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
10. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
11. China Kangtai Cactus Biotech Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... DUBLIN , May 20, 2015 Research ... announced the addition of the "2015 Global ... to their offering. The primary goal ... of flow cytometry instruments and reagents. Key information ... drive the selection of flow cytometers, predominantly used ...
(Date:5/21/2015)... Kingston, Ontario (PRWEB) May 21, 2015 ... entered into an exclusive North American distribution agreement ... microbiology testing system. , With more than 160 ... of products and services for laboratory and production ... choice, operational excellence and differentiated services to enable ...
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
... option for asthma patients not fully controlled on other ... ... Dey, L.P., an,affiliate of Merck KGaA of Darmstadt, Germany, announced ... partner, Critical Therapeutics, Inc. (Nasdaq: CRTX ). ZYFLO CR(TM),offers twice-daily, ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), a ... proprietary product candidates for the treatment,of cancer ... from,preclinical studies of ANX-514 (docetaxel emulsion) will ... Research (AACR), National Cancer,Institute (NCI) and European ...
... Sept. 26 The National,Alliance for Thrombosis and Thrombophilia ... totaling $1.35 million that will serve as,building blocks for ... year to nearly one million Americans who develop a ... for Disease Control and Prevention (CDC),grants to "launch a ...
Cached Biology Technology:Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma 2Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 2ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 4CDC Awards NATT Funding to Improve Blood Clot Awareness 2CDC Awards NATT Funding to Improve Blood Clot Awareness 3
(Date:5/18/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/11/2015)... Ohio , May 11, 2015  Through a well-rounded ... Ohio had a strong showing at AUVSI,s Unmanned ... These representatives of Ohio,s UAS industry ... and abroad from all points along the UAS ecosystem. ... Development Coalition,s (DDC) Vice President for Aerospace Rich Knoll ...
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... the European Society for Clinical and Economic Aspects of ... an outstanding scientific programme for the upcoming IOF WCO- ... Italy from May 5-8, 2010. Complete programme ... on www.iofwco-ecceo10.org . IOF WCO-ECCEO10 ...
... 1, 2009, St. Louis, MO Micronutrients such as ... in maintaining health. As older adults tend to reduce ... that deficits in these micronutrients lead to medical problems. ... of the Journal of the American Dietetic Association ...
... - Amyris Biotechnologies has announced the publication of an ... toward the production of amorphadiene, a precursor of the ... of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, ... ONE , an open-access journal from the Public Library ...
Cached Biology News:World Congress on Osteoporosis 2010 presents outstanding scientific program 2Many middle-aged and older Americans not getting adequate nutrition 2Milestone achieved toward production of malaria treatment using synthetic biology and fermentation 2
... The Gene Pulser Xcell ... V, 50-60 Hz, is used ... This system includes the main ... (25-3,275 microfarad range) or square-wave ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~5 kDa thymosin beta4 protein....
... Accurate To score SNPs, ... sequencing, the gold standard in DNA analysis. ... The polymorphic locus can be confirmed by ... DNA sequencing also provides sequence context information, ...
... PowerPac basic power supply are used for submerged ... gels. The mini format cell includes a buffer ... bubble. The PowerPac basic power supply, 100-120 and ... mA, and 75 W. Power cord and instructions ...
Biology Products: